Subclinical inflammation with tocilizumab treatment of rheumatoid arthritis: MRI evaluation for 2 years

E-ISSN： 1756-185x|18|1|108-110

ISSN： 1756-1841

Source： INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol.18, Iss.1, 2015-01, pp. : 108-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiarrhythmic Potential of Anticytokine Therapy in Rheumatoid Arthritis: Tocilizumab Reduces Corrected QT Interval by Controlling Systemic Inflammation

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 3, 2015-03 ,pp. : 332-339

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tocilizumab Treatment Leads to a Rapid and Sustained Increase in Treg Cell Levels in Rheumatoid Arthritis Patients: Comment on the Article by Thiolat et al

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 9, 2014-09 ,pp. : 2638-2638

John Wiley & Sons Inc

Access to resources Recommend Favorite

PET/MRI for evaluating subclinical inflammation of ulcerative colitis

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 47, Iss. 3, 2018-03 ,pp. : 737-745

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of early rheumatoid arthritis

By Raza Karim Salmon Mike Buckley Christopher D

Therapy, Vol. 2, Iss. 4, 2005-07 ,pp. : 659-668

Future Medicine

Access to resources Recommend Favorite

Does tocilizumab contribute to elevation of rheumatoid factor and induction of paradoxical syaloadenitis in rheumatoid arthritis patients?

By Martinović Kaliterna Dušanka Aljinović Jure Perković Dijana Marasović Krstulović Daniela Marinović Ivanka Vlak Tonko

Wiener klinische Wochenschrift, Vol. 126, Iss. 3-4, 2014-02 ,pp. : 126-129

Springer Publishing Company

Access to resources Recommend Favorite